Status:
COMPLETED
Sarcopenic Obesity in Neurodisabilities
Lead Sponsor:
Dionyssiotis, Yannis, M.D.
Collaborating Sponsors:
University of Athens
University of Patras
Conditions:
Sarcopenic Obesity
Spinal Cord Injuries
Eligibility:
All Genders
20-90 years
Brief Summary
To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities
Eligibility Criteria
Inclusion
- Persons with
- stroke / cerebrovascular disease
- traumatic brain injury
- multiple sclerosis
- spinal cord injuries (including spinal cord lesions i.e. myelopathies etc.)
Exclusion
- Persons with
- heterotopic ossifications,
- chronic administration of drugs, which promote fat increase
- chronic administration of drugs, which promote bone or muscle loss
- co-existing other diseases such as: endocrinopathies, muscular dystrophies, non-alcoholic fatty liver disease.
Key Trial Info
Start Date :
May 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2022
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03863379
Start Date
May 2 2019
End Date
May 15 2022
Last Update
January 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Rehabilitation Center EKA
Nea Liosia, Athens, Greece, 13122